
Field note
The reality of executive wear and tear.
Burnout, cortisol dysregulation, and the systemic adrenal failure that silently erodes high-output performance over time.
Science-backed Longevity
Physician-directed protocols for testosterone optimization, GLP-1 muscle preservation, comprehensive biomarker tracking, and sustained executive performance.

Field note
Burnout, cortisol dysregulation, and the systemic adrenal failure that silently erodes high-output performance over time.

Clinical
Why a "normal" total result hides the truth. Built around biomarker tracking, continuous hormone optimization, and executive cognitive focus.

Longevity
Reverse cellular depreciation through metabolic health optimization, peptide signaling, and muscle mass preservation.
Closing knowledge
Six systems that quietly degrade under sustained executive load — and the protocol architecture required to protect them.
The Architecture of Decline
Six systemsWeekly physiological field notes for high-performing operators. We break down the exact data, advanced lipidomics, and clinical frameworks required to halt biological depreciation and scale your operational capacity.
Science-backed longevity
Your standard blood panel tells you whether you are alive. It does not tell you how well you will perform, how fast you are aging, or what is silently degrading your body over the next decade. This is what you need to be measuring — and what the numbers should actually look like.
Standard medicine benchmarks your results against a population average. That average includes sedentary men, men with metabolic disease, men who have never deliberately managed their health. Being "in range" means you are tracking along the same trajectory as everyone else — a predictable, steady physical decline through your 50s and 60s.
The Vanguard Benchmark is built differently. Every reference range below is drawn from the narrow physiological window observed in exceptionally resilient, long-lived, high-performing men. These are not aspirational numbers. They are the measurable biological signature of a man who will still be performing at the highest level twenty years from now.
"Normal labs mean you are simply not sick yet. Optimal labs mean your biology is actively working for you — not quietly against you."
01 — Cardiovascular & Lipid Architecture
Standard panels measure Total Cholesterol and LDL — a blunt instrument that misses the real driver of arterial disease: the number of plaque-carrying particles actively pressing against your vessel walls. You can have a "normal" LDL and still be in early cardiovascular decline. Vanguard tracks the exact particle count.
| Biomarker | Standard | Vanguard |
|---|---|---|
| Apolipoprotein B (ApoB) | Up to 119 mg/dL | < 70 mg/dL |
| Lipoprotein(a) [Lp(a)] | < 30 mg/dL | < 10 mg/dL |
| Fasting Triglycerides | Up to 150 mg/dL | 50 – 75 mg/dL |
ApoB counts every plaque-carrying lipoprotein particle. LDL cholesterol measures only their size, not their number. Two men can have identical LDL readings while one carries twice the cardiovascular particle burden of the other.
Why ApoB matters more than LDL
ApoB sits on every plaque-inducing particle in your bloodstream. Lowering this number is the most direct intervention for halting silent arterial damage — irrespective of total cholesterol. Major cardiovascular research now considers ApoB the primary causal risk marker.
Lp(a) — the genetic wildcard
Lipoprotein(a) is largely genetic and cannot be altered by diet or exercise alone. It is one of the most aggressive independent risk factors for early cardiovascular events in otherwise healthy men. Knowing your number early gives you the strategic window to manage it.
Triglycerides as a metabolic signal
High fasting triglycerides mean your liver is continuously packaging excess fuel as circulating fat — an early sign of metabolic stress that appears years before blood sugar or standard lipids give any warning signal.
The standard range problem
An ApoB of 110 mg/dL is clinically "normal." It is also the level at which plaque accumulation is actively progressing in most men over 40. The Vanguard target of under 70 reflects the threshold at which arterial disease halts — not merely slows.
02 — Metabolic Engine & Fuel Flexibility
The standard metabolic panel waits for your blood sugar to fail before raising a flag. But insulin — the hormone your pancreas produces to manage blood sugar — is already showing the strain years earlier. We measure insulin directly, because that is where the early warning signal lives.
| Biomarker | Standard | Vanguard |
|---|---|---|
| Fasting Insulin | Up to 24.9 µIU/mL | 2.0 – 5.0 µIU/mL |
| Hemoglobin A1c (HbA1c) | Up to 5.6% | 4.8% – 5.2% |
| Triglyceride-to-HDL ratio | Up to 3.0 | < 1.0 |
A fasting insulin above 8 µIU/mL indicates your pancreas is working significantly harder than it should — a direct signal of fat-storage mode and early metabolic resistance, years before blood sugar changes.
Why this matters for men over 40
High-stress executives are disproportionately exposed to chronic cortisol elevation, which directly drives insulin resistance via hepatic glucose dumping. The result is a man who eats reasonably well, trains occasionally, but cannot shift visceral fat — because his fuel system is locked in storage mode. Fasting insulin catches this. Fasting glucose does not.
03 — Inflammatory Cascade & Cellular Stress
Systemic inflammation accelerates arterial plaque, destroys joint tissue, impairs brain function, and drives accelerated biological aging. It is the shared upstream driver of cardiovascular disease, cognitive decline, metabolic failure, and cancer. The standard panel does not measure it. Vanguard does.
| Biomarker | Standard | Vanguard |
|---|---|---|
| High-sensitivity CRP (hs-CRP) | Up to 3.0 mg/L | < 0.5 mg/L |
| Homocysteine | Up to 15.0 µmol/L | < 7.0 µmol/L |
hs-CRP above 1.0 mg/L doubles cardiovascular event risk even in the absence of other traditional risk factors. The Vanguard target of under 0.5 reflects the inflammatory baseline of long-lived, cognitively intact men in published longevity cohort studies.
hs-CRP — the body's background fire
Produced by the liver in response to systemic inflammation, hs-CRP is the single most accessible marker of background inflammatory activity that silently erodes arterial walls, joint tissue, and brain cells over years. Tracking above 1.0 mg/L is associated with significantly accelerated cognitive and cardiovascular aging in men over 45.
Homocysteine — the artery scraper
When elevated, homocysteine directly damages the inner lining of your arteries and impairs the methylation pathway responsible for cognitive clarity, DNA repair, and neurotransmitter production. Strongly linked to early dementia risk, yet absent from every standard metabolic panel. Easily managed once identified.
04 — Endocrine Reserve & Free Androgen Power
Most testosterone testing stops at Total T and declares it acceptable if it falls somewhere in a wide reference range built on men aged 17 to 70. Vanguard tracks Free Testosterone — the unbound fraction that actually crosses into your brain and muscle — alongside the binding proteins that regulate how much of your total testosterone is functionally usable.
| Biomarker | Standard | Vanguard |
|---|---|---|
| Free Testosterone | 9.0 – 30.0 pg/mL | 22.0 – 28.0 pg/mL |
| DHEA-Sulfate (DHEA-S) | 100 – 350 µg/dL | 350 – 450 µg/dL |
| Sex Hormone-Binding Globulin (SHBG) | 16.5 – 55.9 nmol/L | 25 – 35 nmol/L |
The DHEA-S connection
DHEA-S is the foundational adrenal precursor your body uses to produce both testosterone and estrogen. Under sustained high-pressure conditions — the operating environment of most executives over 40 — cortisol production consistently cannibalises DHEA-S, progressively draining your hormonal reserve. A man can be on TRT and still be functionally depleted at this level.
05 — Cellular Energy & Mitochondrial Health
Mitochondria are the cellular engines that convert the food you eat into usable energy (ATP). When they become compromised by oxidative stress, toxic accumulation, or nutrient deficiency, no amount of sleep, caffeine, or willpower fills the gap. This is the biological explanation for the mid-afternoon energy crashes that no lifestyle adjustment seems to fix.
| Biomarker | Standard | Vanguard |
|---|---|---|
| Uric Acid | 3.7 – 8.0 mg/dL | 4.0 – 5.5 mg/dL |
| Coenzyme Q10 (CoQ10) | > 0.50 µg/mL | > 2.00 µg/mL |
| Ferritin | 30 – 400 ng/mL | 50 – 150 ng/mL |
CoQ10 declines progressively from age 30. Men on statins face accelerated depletion. At sub-optimal levels, mitochondrial ATP production drops — presenting as chronic fatigue, recovery failure, and cardiac efficiency loss that no standard panel will identify.
06 — Lean Mass Architecture & Body Composition
After 35, men lose between 1–2% of skeletal muscle mass per year without deliberate intervention. This is called sarcopenia, and it is the invisible accelerant behind metabolic disease, cognitive decline, hormonal failure, and physical fragility in later life. The standard scale and BMI measure none of it.
| Biomarker | Standard | Vanguard |
|---|---|---|
| Skeletal Muscle Mass Index (SMMI via DEXA) | Population average | > 90th percentile |
| Visceral Adipose Tissue (VAT) | < 100 cm² | < 50 cm² |
| Alanine Aminotransferase (ALT) | Up to 50 U/L | < 25 U/L |
1–2%
annual muscle mass loss from age 35 without deliberate intervention
3×
higher all-cause mortality risk in men with low vs. high muscle mass at age 55+
30%
of men with normal BMI carry clinically significant visceral fat — invisible on a standard scale
Visceral fat — the hidden driver of hormonal failure
Visceral fat is not the fat you can pinch. It wraps around your internal organs — your liver, your gut, your heart. It is metabolically active, producing continuous inflammatory signals. It directly drives up aromatase enzyme activity, converting your testosterone into estrogen. This is why men with high visceral fat can have normal Total T and still present with every functional symptom of testosterone deficiency.
07 — Organ Reserve & Detoxification Clearance
High-performance men over 40 carry significant cumulative toxic load — from years of elevated stress hormones, alcohol, pharmaceutical residue, and metabolic waste. Standard organ function tests wait for significant damage before flagging anything. Vanguard tracks the early warning markers.
| Biomarker | Standard | Vanguard |
|---|---|---|
| Gamma-Glutamyl Transferase (GGT) | Up to 60 U/L | < 20 U/L |
| Cystatin C (Glomerular Filtration) | Variable by lab | Optimal baseline |
GGT — the most sensitive liver signal
GGT is the most sensitive available marker for oxidative stress and glutathione depletion in the liver. Standard panels allow it to reach 60 U/L before concern. At that level, your liver's capacity to neutralise toxins, metabolise hormones, and support detoxification is already meaningfully impaired. The Vanguard target of under 20 is the level consistently seen in men with the lowest all-cause mortality risk across major epidemiological datasets.
Cystatin C — the kidney marker your panel skips
Standard creatinine-based kidney tests are heavily influenced by muscle mass — meaning a muscular man can show a falsely reassuring kidney score. Cystatin C is produced at a constant rate regardless of muscle mass, making it an independent, unbiased marker of actual filtration rate. Essential for any man using advanced longevity protocols, peptide therapies, or pharmaceutical optimisation.
Summary
This is the distance between a result that will not flag any concern in a routine check-up, and a result that reflects a biological system actively working in your favour over the next 20 years.
Each bar shows the scale of the gap between a 'clinically acceptable' result and the Vanguard benchmark. In most cases the difference is not marginal — it reflects an entirely different biological trajectory over the next decade.
The metrics above represent the seven biological systems that determine how well a man over 40 will perform — cognitively, physically, hormonally — over the next decade. They are not exotic or experimental. They are available through standard diagnostic networks today. What changes is the standard you hold them to.
The difference between a man who is merely "not sick" at 55 and a man genuinely performing at the level of his best years is not genetics. It is measurement, clarity, and consistent optimisation of the right variables.
"You cannot protect an asset you have never properly audited. These are the numbers that tell you what is actually happening inside your biology — years before anything becomes a clinical problem."
Get your complete baseline.
Vanguard Man runs 350+ biomarkers mapped against the benchmark standards on this page — not population averages. Every result is returned with physician interpretation and a complete optimisation protocol built entirely around your data.
Become a memberWhat you get